· 25/09/2022

MANTRA: evaluating the association between retinal sensitivity and retinal flow in AMD

· 22/05/2022Recruiting

VELODROME: efficacy, safety and pharmacokinetics of ranibizumab 100 mg/ml through a PDS in patients with nDMAE

· 15/05/2022

TALON (Extension): efficacy and safety of brolucizumab 6 mg in a maximum interval dosing schedule of 20 weeks for patients with nDMAE

· 15/05/2022

GALE: evaluating the long-term safety and efficacy of intravitreal pegcetacoplan in patients with GA secondary to AMD

· 11/04/2022Recruiting

IONIS: safety and efficacy of multiple doses of IONIS-FB-LRX

· 04/04/2022

Avonelle X: long-term safety and tolerability of the administration of intravitreal injections of Faricimab

· 15/02/2022Recruiting

RADIS: Observational Study of Rare Retinal Pathologies

· 18/11/2020

Phase I/IIa study in subjects with Pigmentary Retinosis

· 18/11/2020

KODIAK: A phase II study in patients with the exudative form of AMD

· 18/11/2020Recruiting

REVERS: Study using postbiotics in AMD patients

· 14/02/2020

Clinical trial OAKS-DERBY: efficacy and safety of pegcetacoplan in the treatment of geographic atrophy secondary to AMD

· 26/11/2019

TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD

· 13/11/2019Recruiting

Research project MICROBEYEOME

· 09/04/2019

LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration

· 10/05/2018

Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease